Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sarcoplasmic/endoplasmic reticulum calcium ATPase (PfATP6) is a P-type Ca2+-transporting ATPase encoded by the malaria parasite Plasmodium falciparum. It is the parasite's ortholog of the mammalian sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) and plays an essential role in maintaining intracellular calcium homeostasis by pumping calcium ions from the cytosol into the endoplasmic reticulum. PfATP6 is a validated therapeutic target, historically proposed as a primary target of the artemisinin class of antimalarial drugs (including artemisinin, artesunate, artemether, and dihydroartemisinin), which inhibit its calcium-pumping activity and disrupt calcium signaling, leading to parasite death. Although some controversy exists regarding whether artemisinins act solely or primarily through PfATP6, genetic studies and functional assays in heterologous expression systems (such as yeast and Xenopus oocytes) support its interaction with these drugs. Mutations in the pfatp6 gene, such as L263E, S769N, and A623E, have been associated with reduced susceptibility to artemisinins in vitro and in field isolates, making them important markers for monitoring drug resistance. Additionally, PfATP6 is inhibited by other SERCA inhibitors like thapsigargin and cyclopiazonic acid, though with a distinct pharmacological profile compared to mammalian SERCA.
Inhibition of calcium transport and ATPase activity, leading to disruption of intracellular calcium homeostasis and parasite cell death
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sarcoplasmic/endoplasmic reticulum calcium ATPase (PfATP6) (PfATP6).